Huadong Medicine Co., Ltd
000963
Rank in Stocks
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Share Price
$3.89
Market Cap
$6.83B
Change (1 day)
-2.22%
Change (1 year)
-30.58%
Country
CN
Trade Huadong Medicine Co., Ltd (000963)
Category
Healthcare
EPS for Huadong Medicine Co., Ltd (000963)
EPS as of June 2026 TTM: $0.30
According to Huadong Medicine Co., Ltd latest financial reports and stock price the company's current EPS (TTM) is $0.30. At the end of 2024 the company had a EPS of $0.28 an increase over its 2023 EPS that were of $0.23.
EPS history for Huadong Medicine Co., Ltd from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.30 | 5.36% |
| 2025 | $0.28 | 1.20% |
| 2024 | $0.28 | 20.31% |
| 2023 | $0.23 | 10.42% |
| 2022 | $0.21 | -0.19% |
| 2021 | $0.21 | -15.74% |
| 2020 | $0.25 | 6.62% |
| 2019 | $0.23 | 23.31% |
| 2018 | $0.19 | 19.58% |
| 2017 | $0.16 | 31.21% |
| 2016 | $0.12 | 10.85% |
| 2015 | $0.11 | 39.10% |
| 2014 | $0.08 | 27.05% |
| 2013 | $0.06 | 26.82% |
| 2012 | $0.05 | 26.25% |
| 2011 | $0.04 | 25.74% |
| 2010 | $0.03 | -13.92% |
| 2009 | $0.04 | 118.63% |
| 2008 | $0.02 | 6.62% |
| 2007 | $0.02 | 69.66% |
| 2006 | $0.01 | 45.90% |
| 2005 | $0.01 | 221.05% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | -34.48% |
| 2002 | 0.00 | -12.12% |
| 2001 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 88.58% |
IN
|
